Article
Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Dec 2018
Descarpentries Clotilde, Leprêtre Frédéric, Escande Fabienne, Kherrouche Zoulika, Figeac Martin, Sebda Shéhérazade, Baldacci Simon, Grégoire Valérie, Jamme Philippe, Copin Marie-Christine, Tulasne David, Cortot Alexis B
Abstract excerpt
INTRODUCTION: Genomic alterations affecting splice sites of MNNG HOS transforming gene (MET) exon 14 were recently identified in NSCLC patients. Objective responses to MET tyrosine kinase inhibitors have been reported in these patients. Thus, detection of MET exon 14 splice site mutations represents a major challenge. So far, most of these alterations were found by full-exome sequencing or large capture-based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
